ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...

As the title of this article gave away, that company is ResMed (NYSE:RMD), a fast-growing healthcare company. My most recent article on this company was published on October 30, 2023. Back then ...

ResMed (RMD) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

Wolfe Research analyst Michael Polark downgraded the rating on Resmed (RMD – Research Report) to a Sell yesterday, setting a price target of $180.00. Michael Polark has given his Sell rating due ...